Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease

CONCLUSIONS: This study shows a modest benefit of tolvaptan in ADPKD patients, as well as safety concerns.PMID:38616432 | DOI:10.1016/j.medcli.2024.01.026

Source: Medicina Clinica - April 15, 2024 Category: General Medicine Authors: Lorenzo Cantarelli Marta Guti érrez Valencia Leire Leache Alegria Luis Carlos Sainz Fernandez Juan Erviti Lopez Fernando Guti érrez Nicolas Gloria Julia Nazco Casariego Source Type: research